Norwegian Industry Asks Government To Match Danish Response To US Pricing Pressures

Norway must address low willingness to pay for innovation to ensure access to medicines and a robust life sciences sector. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Europe